Skip to content

PT-141

PT-141 (Bremelanotide) is an FDA-approved synthetic peptide that acts as a melanocortin receptor agonist, specifically targeting MC3R and MC4R receptors in the central nervous system.

Also known as: Melanocortin Receptor Agonist, Sexual Dysfunction Treatment

Typical Dose 1.75mg
Storage Refrigerate reconstituted; store lyophilized powder away from light
How Often As needed, max 1 dose/24hr

Overview

PT-141 (Bremelanotide) is an FDA-approved synthetic peptide that acts as a melanocortin receptor agonist, specifically targeting MC3R and MC4R receptors in the central nervous system. Unlike traditional ED medications that work through vascular mechanisms, PT-141 directly influences sexual arousal pathways in the brain, making it effective for both male and female sexual dysfunction.

Key Benefits

  • Hypoactive Sexual Desire Disorder (HSDD)
  • Erectile Dysfunction
  • Female Sexual Arousal Disorder

FDA-approved route with predictable absorption, works within 45 minutes, effective for both male and female sexual dysfunction

Mechanism of Action

Activates melanocortin receptors (MC3R/MC4R) in the central nervous system, triggering sexual arousal pathways independent of vascular mechanisms

Pharmacokinetics

Peak plasma concentration: 1 hr. Elimination half-life: 2.7 hrs. Largely cleared by: ~13.5 hrs.

Research Protocols Injectable

GoalDoseFrequencyRoute
Female HSDD (FDA-approved)1.75mgAs needed, max 1 dose/24hrSubcutaneous
Male Erectile Dysfunction1-2mgAs needed, 45-60min before activitySubcutaneous
Female Arousal Disorder0.75-1.25mgAs needed, max 1 dose/24hrSubcutaneous
Low Starting Dose0.5mgTest dose to assess toleranceSubcutaneous

Research protocols from published literature — not dosing recommendations.

Peptide Interactions

  • Sildenafil/Tadalafil — Monitor Combination: Can be used together but monitor for additive blood pressure effects. PT-141 works centrally while PDE5 inhibitors work peripherally.
  • Melanotan II — Use Caution: Both are melanocortin agonists - combining may lead to excessive melanocortin activation and side effects. Not recommended without medical supervision.
  • Blood Pressure Medications — Monitor Combination: PT-141 can transiently lower blood pressure. Monitor BP closely when combining with antihypertensives.
  • Alcohol — Use Caution: Both can lower blood pressure and cause flushing. Limit alcohol intake when using PT-141 to avoid excessive hypotension.
  • Nitrates — Avoid Combination: Risk of severe hypotension. Do not use PT-141 with nitrate medications for heart conditions.
  • BPC-157 — Compatible: No known interactions. Different mechanisms of action - PT-141 for sexual function, BPC-157 for tissue repair.
  • Testosterone — Synergistic: May work synergistically for sexual dysfunction. PT-141 addresses arousal while testosterone supports libido and function.
  • Kisspeptin — Monitor Combination: Both affect sexual function through different pathways - PT-141 via melanocortin receptors (MC3R/MC4R), Kisspeptin via GnRH stimulation. No receptor overlap but monitor for additive effects on blood pressure and hormonal response.

Peptide Instructions Injectable

Supplies:

  • Bacteriostatic water (BAC water)
  • Insulin syringes (29-31 gauge)
  • Alcohol swabs
  • PT-141 lyophilized powder vial

How to Reconstitute Injectable

  1. 1Allow vial to reach room temperature (15-20 minutes)
  2. 2Clean vial top with alcohol swab and allow to dry
  3. 3Calculate required bacteriostatic water volume using the calculator below
  4. 4Draw calculated volume of bacteriostatic water into syringe
  5. 5Inject water slowly down the inside wall of the vial (never directly onto powder)
  6. 6Gently swirl until powder completely dissolves (never shake)
  7. 7Solution should be clear - discard if cloudy or contains particles
  8. 8Store reconstituted solution in refrigerator at 2-8°C

What to Expect Injectable

First 30-45 minutes: May experience mild nausea or facial flushing. 45-90 minutes: Onset of effects - increased arousal and desire. 2-4 hours: Peak effects - enhanced sexual response and satisfaction. 6-12 hours: Effects gradually diminish. Long-term: No tolerance development reported with intermittent use.

Side Effects & Safety

Common side effects: nausea (40%), flushing (20%), headache (11%). Take anti-nausea medication 30 minutes before if prone to nausea. Monitor blood pressure - can cause transient decrease. Not for use with uncontrolled hypertension or cardiovascular disease. Avoid alcohol to minimize blood pressure effects. FDA black box warning for blood pressure effects.

Common side effects: nausea (40%), flushing (20%), headache (11%). Take anti-nausea medication 30 minutes before if prone to nausea. Monitor blood pressure - can cause transient decrease. Not for use with uncontrolled hypertension or cardiovascular disease. Avoid alcohol to minimize blood pressure effects. FDA black box warning for blood pressure effects.

Community Insights

PT-141 should be stored at Refrigerate reconstituted solution (2-8°C), use within 30 days.

References

  1. FDA Approval Trial for Hypoactive Sexual Desire Disorder (2019) · 2019
  2. Male Erectile Dysfunction Clinical Trial (2017) · 2017
  3. Mechanism of Action Study (2016) · 2016
  4. Female Sexual Arousal Disorder Trial (2013) · 2013

Research reference only. Not medical advice.